vecuronium bromide has been researched along with Kidney Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dasta, JF; Watling, SM | 1 |
| Caldwell, JE; Gruenke, LD; Matthay, MA; Miller, RD; Segredo, V; Sharma, ML | 1 |
| Agoston, S; Caldwell, JE; Gruenke, LD; Khuenl-Brady, KS; Miller, RD; Segredo, V; Sharma, ML; Shin, YS | 1 |
| Agoston, S; Bencini, AF; Kersten, UW; Lienhart, A; Meistelman, C; Scaf, AH; Schwarz, S; Sohn, YJ | 1 |
| Miller, RD | 1 |
| Aoki, T | 1 |
| Van de Walle, J; Vanacker, BF | 1 |
1 review(s) available for vecuronium bromide and Kidney Diseases
| Article | Year |
|---|---|
Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature.
Topics: Adrenal Cortex Hormones; Atracurium; Chemical and Drug Induced Liver Injury; Confounding Factors, Epidemiologic; Critical Care; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Humans; Infusions, Intravenous; Intensive Care Units; Kidney Diseases; Liver Diseases; Metabolic Clearance Rate; Paralysis; Risk Factors; Time Factors; Vecuronium Bromide | 1994 |
7 other study(ies) available for vecuronium bromide and Kidney Diseases
| Article | Year |
|---|---|
Persistent paralysis in critically ill patients after long-term administration of vecuronium.
Topics: Critical Illness; Female; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Magnesium; Male; Neuromuscular Junction; Paralysis; Respiration, Artificial; Retrospective Studies; Sex Factors; Time Factors; Vecuronium Bromide | 1992 |
Pharmacokinetics, neuromuscular effects, and biodisposition of 3-desacetylvecuronium (Org 7268) in cats.
Topics: Animals; Cats; Chemical and Drug Induced Liver Injury; Female; Galactosamine; Kidney Diseases; Liver Diseases; Male; Neuromuscular Blocking Agents; Tissue Distribution; Vecuronium Bromide | 1991 |
Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.
Topics: Adult; Anesthesia, General; Female; Humans; Kidney; Kidney Diseases; Kinetics; Male; Middle Aged; Neuromuscular Blocking Agents; Pancuronium; Vecuronium Bromide | 1986 |
Pharmacokinetics of atracurium and other non-depolarizing neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction.
Topics: Animals; Atracurium; Child; Child, Preschool; Dogs; Humans; Isoquinolines; Kidney Diseases; Kinetics; Liver Diseases; Neuromuscular Blocking Agents; Pancuronium; Vecuronium Bromide | 1986 |
[Effect of portacaval shunt and/or renal vessel ligation on disposition of muscle relaxants].
Topics: Animals; Atracurium; Isoquinolines; Kidney Diseases; Liver Diseases; Male; Neuromuscular Blocking Agents; Pancuronium; Portacaval Shunt, Surgical; Rats; Rats, Inbred Strains; Renal Circulation; Tubocurarine; Vecuronium Bromide | 1986 |
The neuromuscular blocking action of vecuronium in normal patients and in patients with no renal function and interaction vecuronium-tobramycin in renal transplant patients.
Topics: Adult; Aged; Drug Synergism; Female; Hemodynamics; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Nephrectomy; Neuromuscular Blocking Agents; Pancuronium; Premedication; Tobramycin; Vecuronium Bromide | 1986 |
Recurarisation after vecuronium?
Topics: Female; Humans; Kidney Diseases; Neostigmine; Vecuronium Bromide | 1988 |